EI
AZN icon

Ellevest Inc’s AstraZeneca AZN Stock Holding History

Ellevest Inc’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
6,725
+967
+17% +$182K 0.15% 104
2026
Q1 		$1.14M Buy
5,758
+1,310
+29% +$253K 0.16% 89
2025
Q4 		$818K Buy
4,448
+18
+0.4% +$3.16K 0.11% 130
2025
Q3 		$680K Buy
4,430
+22
+0.5% +$3.33K 0.1% 155
2025
Q2 		$616K Sell
4,408
-354
-7% -$49.6K 0.1% 155
2025
Q1 		$700K Sell
4,762
-3,285
-41% -$475K 0.05% 147
2024
Q4 		$1.05M Sell
8,047
-2,540
-24% -$356K 0.06% 99
2024
Q3 		$1.65M Sell
10,587
-436
-4% -$70.4K 0.09% 67
2024
Q2 		$1.72M Buy
11,023
+2,172
+25% +$327K 0.1% 58
2024
Q1 		$1.2M Buy
8,851
+921
+12% +$122K 0.07% 80
2023
Q4 		$1.07M Sell
7,930
-265
-3% -$34.4K 0.07% 78
2023
Q3 		$1.11M Buy
8,195
+676
+9% +$92.3K 0.09% 62
2023
Q2 		$1.08M Buy
7,519
+143
+2% +$21K 0.08% 64
2023
Q1 		$1.02M Buy
7,376
+200
+3% +$26.9K 0.08% 63
2022
Q4 		$973K Buy
7,176
+1,115
+18% +$140K 0.08% 58
2022
Q3 		$665K Sell
6,061
-1,585
-21% -$201K 0.06% 72
2022
Q2 		$1.01M Buy
7,646
+615
+9% +$80.7K 0.09% 49
2022
Q1 		$933K Buy
7,031
+1,808
+35% +$217K 0.08% 59
2021
Q4 		$608K Sell
5,223
-388
-7% -$45.7K 0.05% 80
2021
Q3 		$674K Buy
5,611
+1,200
+27% +$140K 0.07% 73
2021
Q2 		$528K Buy
4,411
+1,140
+35% +$125K 0.05% 84
2021
Q1 		$325K Buy
3,271
+531
+19% +$53.4K 0.04% 117
2020
Q4 		$274K Buy
2,740
+558
+26% +$59.1K 0.04% 117
2020
Q3 		$239K Buy
2,182
+431
+25% +$47.9K 0.04% 114
2020
Q2 		$185K Buy
1,751
+662
+61% +$68.4K 0.04% 122
2020
Q1 		$97K Buy
1,089
+532
+96% +$50.1K 0.03% 143
2019
Q4 		$56K Buy
557
+432
+346% +$40.7K 0.02% 162
2019
Q3 		$11K Buy
125
+7
+6% +$607 ﹤0.01% 220
2019
Q2 		$10K Buy
+118
New +$9.25K ﹤0.01% 250

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ellevest Inc's AZN Position: Q2 2026 in Review

Ellevest Inc increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $182K and bringing the position to 6,725 shares worth $1.23M. The position accounts for 0.15% of the portfolio, ranked #104.

Ellevest Inc first reported a position in AZN in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.72M in Q2 2024. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Ellevest Inc held 6,725 shares of AstraZeneca worth $1.23M as of Q2 2026.
  • Ellevest Inc bought 967 AstraZeneca shares in Q2 2026, an estimated $182K.
  • AstraZeneca made up 0.15% of Ellevest Inc's portfolio in Q2 2026, its #104 holding.
  • Ellevest Inc first reported a position in AstraZeneca in Q2 2019 and has held it in 29 quarters since.
  • Ellevest Inc's AstraZeneca position peaked at $1.72M in Q2 2024.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.